Qu Q, Jiang R, Luo F, Mou S, Zhang Z, Zhu W
Medicine (Baltimore). 2024; 103(37):e39560.
PMID: 39287293
PMC: 11404955.
DOI: 10.1097/MD.0000000000039560.
Xue C, Sun G, Wang N, Liu X, He G, Wei Y
Asian Spine J. 2024; 18(3):336-345.
PMID: 38917853
PMC: 11222884.
DOI: 10.31616/asj.2023.0438.
Ma D, Wang Y, Zhang X, Su D, Wang C, Liu H
Calcif Tissue Int. 2024; 114(4):397-408.
PMID: 38483546
DOI: 10.1007/s00223-024-01185-5.
Li Q, Yang Z, Zhu M, Li J, Lu C, Li Z
Int Orthop. 2024; 48(5):1323-1330.
PMID: 38467869
DOI: 10.1007/s00264-024-06145-0.
Yuan H, Wang C, Liu L, Wang C, Zhang Z, Qu S
Pharmgenomics Pers Med. 2023; 16:925-932.
PMID: 37920752
PMC: 10619967.
DOI: 10.2147/PGPM.S425357.
Prevalent vertebral fractures among urban-dwelling Chinese postmenopausal women: a population-based, randomized-sampling, cross-sectional study.
Xia W, Liu Q, Lv J, Zhang Z, Wu W, Xie Z
Arch Osteoporos. 2022; 17(1):120.
PMID: 36070158
PMC: 9452427.
DOI: 10.1007/s11657-022-01158-x.
Deep-learning image reconstruction for image quality evaluation and accurate bone mineral density measurement on quantitative CT: A phantom-patient study.
Li Y, Jiang Y, Yu X, Ren B, Wang C, Chen S
Front Endocrinol (Lausanne). 2022; 13:884306.
PMID: 36034436
PMC: 9403270.
DOI: 10.3389/fendo.2022.884306.
Efficacy of generic teriparatide and alendronate in Chinese postmenopausal women with osteoporosis: a prospective study.
Li M, Zhang Z, Xue Q, Li Q, Jin X, Dong J
Arch Osteoporos. 2022; 17(1):103.
PMID: 35900607
PMC: 9334369.
DOI: 10.1007/s11657-022-01131-8.
A phase III randomized, double-blind, placebo-controlled trial of the denosumab biosimilar QL1206 in postmenopausal Chinese women with osteoporosis and high fracture risk.
Zhang H, Gu J, Chao A, Cheng Q, Teng D, Yu J
Acta Pharmacol Sin. 2022; 44(2):446-453.
PMID: 35896694
PMC: 9889741.
DOI: 10.1038/s41401-022-00954-y.
Gene Polymorphisms and the Bone Mineral Density Response to Alendronate Therapy in Postmenopausal Chinese Women with Low Bone Mass.
Zhao J, Liu L, Lv S, Wang C, Yue H, Zhang Z
Pharmgenomics Pers Med. 2022; 14:1669-1678.
PMID: 34992429
PMC: 8711734.
DOI: 10.2147/PGPM.S344818.
Prevalence of Osteoporosis and Fracture in China: The China Osteoporosis Prevalence Study.
Wang L, Yu W, Yin X, Cui L, Tang S, Jiang N
JAMA Netw Open. 2021; 4(8):e2121106.
PMID: 34398202
PMC: 8369359.
DOI: 10.1001/jamanetworkopen.2021.21106.
Health-related quality of life in men with osteoporosis: a systematic review and meta-analysis.
Hu J, Zheng W, Zhao D, Sun L, Zhou B, Liu J
Endocrine. 2021; 74(2):270-280.
PMID: 34165773
DOI: 10.1007/s12020-021-02792-0.
The Assessment of the Osteoporosis Self-Assessment Tool for Asians and Calcaneal Quantitative Ultrasound in Identifying Osteoporotic Fractures and Falls Among Chinese People.
Gao C, Song H, Chen B, Zhang Z, Yue H
Front Endocrinol (Lausanne). 2021; 12:684334.
PMID: 34040589
PMC: 8143027.
DOI: 10.3389/fendo.2021.684334.
Exploring the Relationship of Bone Turnover Markers and Bone Mineral Density in Community-Dwelling Postmenopausal Women.
Wei X, Zhang Y, Xiang X, Sun M, Sun K, Han T
Dis Markers. 2021; 2021:6690095.
PMID: 33968284
PMC: 8084639.
DOI: 10.1155/2021/6690095.
Opportunistic Screening Using Low-Dose CT and the Prevalence of Osteoporosis in China: A Nationwide, Multicenter Study.
Cheng X, Zhao K, Zha X, Du X, Li Y, Chen S
J Bone Miner Res. 2020; 36(3):427-435.
PMID: 33145809
PMC: 7988599.
DOI: 10.1002/jbmr.4187.
Association of HIVEP3 Gene and Lnc RNA with Femoral Neck Bone Mineral Content and Hip Geometry by Genome-Wide Association Analysis in Chinese People.
Hu W, He J, Qi L, Wang C, Yue H, Gu J
Int J Endocrinol. 2020; 2020:6929073.
PMID: 33110425
PMC: 7579678.
DOI: 10.1155/2020/6929073.
Chinese expert consensus on the diagnosis of osteoporosis by imaging and bone mineral density.
Cheng X, Yuan H, Cheng J, Weng X, Xu H, Gao J
Quant Imaging Med Surg. 2020; 10(10):2066-2077.
PMID: 33014734
PMC: 7495321.
DOI: 10.21037/qims-2020-16.
